Indiana's religious-freedom law fell off the stupid tree and hit every branch on the way down, says Jake Novak.
Signed contracts to buy existing homes rose 3.1 percent from January, according to the National Association of Realtors.
Check out the inside of the ultimate high-end home of billionaire Jeff Greene, with CNBC's Robert Frank.
Iran is trying to expand its empire much like Hitler's Germany before World War II, former CIA chief James Woolsey tells CNBC.
One of the U.K.'s most successful hedge fund managers has spoken of the benefits of the "emotionless systematic approach" of automated stock-picking.
The U.S. economy is headed for another good year, according to the latest forecast from a group of business economists.
Comedy Central will announce that Trevor Noah has been chosen as the new host of "The Daily Show."
Personal details of world leaders—including Barack Obama and Vladimir Putin—were accidentally disclosed by G-20 organizers, The Guardian reports.
Protecting a stock portfolio against market volatility means diversifying into an array of sectors that buffer holdings.
Consumer spending barely rose in February as households boosted savings to their highest level in more than two years.
CNBC's Morgan Brennan and Tom's Guide Editor-in-Chief Mark Spoonauer talk about Pebble's place in the smart watch market.
“Mad Money” host Jim Cramer sees a pulse back in biotechs. Time to jump in?
Craig Johnson of Piper Jaffray says the S&P will hit 2,350 before the year is out.
Stress is the number one epidemic of our civilization, leading to both mental and physical ailments, best-selling author Deepak Chopra tells CNBC.
The technical and fundamental reasons why biotech stocks could be a great buy right now.
Janet Yellen says "secular stagnation" is a potential concern for the Fed. Here's what that means, and why it matters to policy.
Shareholder payouts by large companies in Europe soared over the last financial year, according to new research from Markit.
As talks between the West and Iran continue, analysts have warned that a successful deal could further compound the glut in global oil markets.
UnitedHealth Group unit OptumRx Corp agreed to buy pharmacy benefit manager Catamaran Corp in a deal worth $12.78 billion.
Former Federal Reserve Chair Ben Bernanke is defending the low federal funds rate, reports CNBC's Steve Liesman.